A rhinovirus vaccine evokes T cell mediated cross-reactive immunity in a preclinical model of rhinovirus infection
Stephen Michael Shaw, Chloe Julia Pyle, Neeta D Patel, Michael R. Edwards, Ziyin Wang, John S. Tregoning, Patricia Londoño-Hayes, Paul Hamblin, Richard P. Butt, Sebastian Lennox Johnston
This study evaluates a rhinovirus (RV) vaccine, showing it induces cross-reactive T cell immunity and protection against heterotypic RV infection in mice.
bioRxiv · Jan 7, 2026 · PreprintImmunology